Arcturus Therapeutics (ARCT) Insider Trading & Ownership $12.83 +0.33 (+2.64%) Closing price 04:00 PM EasternExtended Trading$12.69 -0.14 (-1.09%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock Arcturus Therapeutics (NASDAQ:ARCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.29 M Get ARCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcturus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARCT Insider Buying and Selling by Quarter Arcturus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/15/2024Pad ChivukulaCOOSell12,000$20.76$249,120.00 6/5/2024Pad ChivukulaCOOSell114$45.00$5,130.00 6/3/2024Pad ChivukulaCOOSell26,000$40.01$1,040,260.00 (Data available from 1/1/2013 forward) ARCT Insider Trading Activity - Frequently Asked Questions Who is on Arcturus Therapeutics's Insider Roster? The list of insiders at Arcturus Therapeutics includes Keith C Kummerfeld, Magda Marquet, and Pad Chivukula. Learn more on insiders at ARCT. What percentage of Arcturus Therapeutics stock is owned by insiders? 15.30% of Arcturus Therapeutics stock is owned by insiders. Learn more on ARCT's insider holdings. Which Arcturus Therapeutics insiders have been selling company stock? The following insiders have sold ARCT shares in the last 24 months: Keith C Kummerfeld ($243,880.00), and Pad Chivukula ($4,115,094.35). How much insider selling is happening at Arcturus Therapeutics? Insiders have sold a total of 133,157 Arcturus Therapeutics shares in the last 24 months for a total of $4,358,974.35 sold. Arcturus Therapeutics Key ExecutivesMr. Joseph E. Payne M.Sc. (Age 52)Founder, President, CEO & Director Compensation: $906.5kDr. Padmanabh Chivukula Ph.D. (Age 45)Founder, Chief Scientific Officer, COO & Secretary Compensation: $687.5kMr. Andrew H. Sassine MBA (Age 60)CFO & Director Compensation: $687.5kMr. Lance KurataChief Legal OfficerMs. Neda SafarzadehVice President and Head of IR/PR & MarketingMs. Natash O. BowmanChief Human Resources OfficerMr. Kevin T. SkolChief Business OfficerDr. Juergen Froehlich FCPh (Age 68)M.D., MBA, Chief Medical Officer Dr. Igor Smolenov M.D.Ph.D., Chief Development OfficerMs. Roberta DuncanChief Strategy Officer More Insider Trading Tools from MarketBeat Related Companies ARS Pharmaceuticals Insider Trades Structure Therapeutics Insider Trades Ocular Therapeutix Insider Trades Dyne Therapeutics Insider Trades Ardelyx Insider Trades Iovance Biotherapeutics Insider Trades Amphastar Pharmaceuticals Insider Trades Syndax Pharmaceuticals Insider Trades Adaptive Biotechnologies Insider Trades Aurinia Pharmaceuticals Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:ARCT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARCT Stock Free ARCT Stock Alerts